STAT3 and cancer: Overactivation of STAT3 is also attributed to the presence of cancer stem cells (CSCs) or tumor‐initiating cells (TICs), which contribute to drug resistance, tumor metastasis, and recurrence (Prasetyanti and Medema 2017).